These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

632 related articles for article (PubMed ID: 30047189)

  • 21. A comparison of the malignancy incidence among patients with psoriatic arthritis and patients with rheumatoid arthritis in a large US cohort.
    Gross RL; Schwartzman-Morris JS; Krathen M; Reed G; Chang H; Saunders KC; Fisher MC; Greenberg JD; Putterman C; Mease PJ; Gottlieb AB; Kremer JM; Broder A
    Arthritis Rheumatol; 2014 Jun; 66(6):1472-81. PubMed ID: 24591475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis.
    Roubille C; Richer V; Starnino T; McCourt C; McFarlane A; Fleming P; Siu S; Kraft J; Lynde C; Pope J; Gulliver W; Keeling S; Dutz J; Bessette L; Bissonnette R; Haraoui B
    Ann Rheum Dis; 2015 Mar; 74(3):480-9. PubMed ID: 25561362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular risk factors in gout, psoriatic arthritis, rheumatoid arthritis and ankylosing spondylitis: a cross-sectional survey of patients in Western Sweden.
    Landgren AJ; Dehlin M; Jacobsson L; Bergsten U; Klingberg E
    RMD Open; 2021 May; 7(2):. PubMed ID: 34031261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study.
    Ogdie A; Yu Y; Haynes K; Love TJ; Maliha S; Jiang Y; Troxel AB; Hennessy S; Kimmel SE; Margolis DJ; Choi H; Mehta NN; Gelfand JM
    Ann Rheum Dis; 2015 Feb; 74(2):326-32. PubMed ID: 25351522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subclinical impairment of myocardial and endothelial functionality in very early psoriatic and rheumatoid arthritis patients: Association with vitamin D and inflammation.
    Lo Gullo A; Rodríguez-Carrio J; Aragona CO; Dattilo G; Zito C; Suárez A; Loddo S; Atteritano M; Saitta A; Mandraffino G
    Atherosclerosis; 2018 Apr; 271():214-222. PubMed ID: 29524864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project.
    Castañeda S; Martín-Martínez MA; González-Juanatey C; Llorca J; García-Yébenes MJ; Pérez-Vicente S; Sánchez-Costa JT; Díaz-Gonzalez F; González-Gay MA;
    Semin Arthritis Rheum; 2015 Jun; 44(6):618-26. PubMed ID: 26058345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiometabolic comorbidities in RA and PsA: lessons learned and future directions.
    Ferguson LD; Siebert S; McInnes IB; Sattar N
    Nat Rev Rheumatol; 2019 Aug; 15(8):461-474. PubMed ID: 31292564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comorbidities Associated with Psoriatic Arthritis Compared with Non-psoriatic Spondyloarthritis: A Cross-sectional Study.
    Haque N; Lories RJ; de Vlam K
    J Rheumatol; 2016 Feb; 43(2):376-82. PubMed ID: 26669922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence and risk factors of major cardiovascular events in rheumatoid arthritis and psoriatic arthritis: A population-based cohort study.
    Meng H; Lam SH; So H; Tam LS
    Semin Arthritis Rheum; 2024 Apr; 65():152416. PubMed ID: 38368730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment persistence among patients with rheumatoid disease (RA, AS, PsA) treated with subcutaneous biologics in Germany.
    Lyu R; Govoni M; Ding Q; Black CM; Kachroo S; Fan T; Ogbonnaya A; Donga P; Hill J; Makin C
    Rheumatol Int; 2016 Jan; 36(1):143-53. PubMed ID: 26314368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comorbidities in psoriatic arthritis: a systematic review and meta-analysis.
    Gupta S; Syrimi Z; Hughes DM; Zhao SS
    Rheumatol Int; 2021 Feb; 41(2):275-284. PubMed ID: 33423070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tuberculosis among patients treated with TNF inhibitors for rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis in Slovenia: a cohort study.
    Rotar Z; Svetina P; Tomsic M; Hočevar A; Prapotnik S
    BMJ Open; 2020 Feb; 10(2):e034356. PubMed ID: 32029494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High prevalence of diabetes in patients with rheumatoid arthritis: results from a questionnaire survey linked to claims data.
    Albrecht K; Luque Ramos A; Hoffmann F; Redeker I; Zink A
    Rheumatology (Oxford); 2018 Feb; 57(2):329-336. PubMed ID: 29121263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The comparative one-year performance of anti-tumor necrosis factor alpha drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: results from a longitudinal, observational, multicenter study.
    Heiberg MS; Koldingsnes W; Mikkelsen K; Rødevand E; Kaufmann C; Mowinckel P; Kvien TK
    Arthritis Rheum; 2008 Feb; 59(2):234-40. PubMed ID: 18240258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between metabolic syndrome and carotid intima-media thickness: cross-sectional comparison between psoriasis and psoriatic arthritis.
    Lin YC; Dalal D; Churton S; Brennan DM; Korman NJ; Kim ES; Husni ME
    Arthritis Care Res (Hoboken); 2014 Jan; 66(1):97-103. PubMed ID: 23983044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Higher Incidence Rates of Comorbidities in Patients with Psoriatic Arthritis Compared with the General Population Using U.S. Administrative Claims Data.
    Kaine J; Song X; Kim G; Hur P; Palmer JB
    J Manag Care Spec Pharm; 2019 Jan; 25(1):122-132. PubMed ID: 29694270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of cardiovascular-related comorbidity in ankylosing spondylitis, psoriatic arthritis and psoriasis in primary care: a matched retrospective cohort study.
    Ahmed N; Prior JA; Chen Y; Hayward R; Mallen CD; Hider SL
    Clin Rheumatol; 2016 Dec; 35(12):3069-3073. PubMed ID: 27485152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence and Management of Cardiovascular Risk Factors in Psoriatic Arthritis and Rheumatoid Arthritis: A Population-Based Study.
    Jafri K; Bartels CM; Shin D; Gelfand JM; Ogdie A
    Arthritis Care Res (Hoboken); 2017 Jan; 69(1):51-57. PubMed ID: 27696731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of minimal disease activity in Australian patients with Psoriatic Arthritis: Assessing the outcome of national funding criteria for biologic disease-modifying antirheumatic drug prescribing.
    Pontifex EK; Dissanayake K; Bursill D; Gill T
    Int J Rheum Dis; 2019 Feb; 22(2):262-268. PubMed ID: 30450819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Higher depression rates and similar cardiovascular comorbidity in psoriatic arthritis compared with rheumatoid arthritis and diabetes mellitus.
    Fragoulis GE; Evangelatos G; Tentolouris N; Fragkiadaki K; Panopoulos S; Konstantonis G; Iliopoulos A; Chatzidionysiou K; Sfikakis PP; Tektonidou MG
    Ther Adv Musculoskelet Dis; 2020; 12():1759720X20976975. PubMed ID: 33343726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.